A retrospective study assessing the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
Latest Information Update: 26 Jun 2021
At a glance
- Drugs Amikacin (Primary)
- Indications Mycobacterium avium complex infections; Nontuberculous mycobacterium infections
- Focus Adverse reactions
- 26 Jun 2021 New trial record
- 19 May 2021 Results presented at the 117th International Conference of the American Thoracic Society